Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
23.87
+0.62 (2.67%)
Oct 19, 2026, 2:03 PM EDT - Market open
Neurogene Employees
Neurogene had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year. That makes Neurogene the 29,706th largest employer in the world and 3,780th in the United States.
Employees
131
Change (1Y)
24
Growth (1Y)
22.43%
Revenue / Employee
n/a
Profits / Employee
-$848,168
Market Cap
477.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Jun 30, 2023 | 82 | - | - |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| Arvinas | 246 |
| Allogene Therapeutics | 152 |
| Aclaris Therapeutics | 73 |
| CytomX Therapeutics | 69 |
| Oculis Holding AG | 60 |
| Eupraxia Pharmaceuticals | 49 |
| Faeth Therapeutics | 29 |
NGNE News
- 11 days ago - Neurogene initiated with an Overweight at JPMorgan - TheFly
- 13 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Neurogene Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 5 weeks ago - Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference - Business Wire
- 2 months ago - Neurogene price target lowered to $65 from $70 at H.C. Wainwright - TheFly
- 2 months ago - Neurogene price target raised to $81 from $69 at Guggenheim - TheFly
- 2 months ago - Neurogene price target lowered to $166 from $180 at Canaccord - TheFly
- 2 months ago - Neurogene Slides: Corporate presentation - Filings